Skip to content

B.D. FARMA: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

B.D. FARMA

BE 0458.341.331
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€191,690
2024 · €175,990+€15,700
Equity
€238,926
2024 · €247,236-€8,310
Cash
€101,184
2024 · €174,070-€72,886
Balance sheet total
€562,484
2024 · €557,532+€4,952

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€77,530

    up €77,530 (+59.3%), from €130,724 to €208,254

    of which Other amounts receivable: +€67,308

  • Cash -€72,886

    down €72,886 (-41.9%), from €174,070 to €101,184

    mainly Contributions, distributions and other (-€200,000) and Receivables within one year (-€77,530)

Equity and liabilities
  • Trade debts +€18,290

    up €18,290 (+24.4%), from €74,848 to €93,139

  • Other debts -€11,725

    down €11,725 (-5.5%), from €212,460 to €200,735

  • Reserves -€8,310

    down €8,310 (-4.5%), from €185,236 to €176,926

    of which Distributable reserves: -€8,310

  • Tax, wage and social debts +€6,697

    up €6,697 (+29.1%), from €22,987 to €29,684

    of which Taxes: +€5,453

Income statement
  • Gross operating margin +€36,607

    up €36,607 (+8.8%), from €414,589 to €451,196

  • Staff costs +€15,463

    up €15,463 (+9.0%), from €171,348 to €186,811

  • Taxes +€5,445

    up €5,445 (+9.0%), from €60,743 to €66,188

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €175,990
Gross operating margin +€36,607
Staff costs -€15,463
Depreciation +€1,471
Other operating charges -€479
Financial income -€891
Financial charges -€101
Taxes -€5,445
Result 2025 €191,690
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€130,539
Investment -€3,425
Financing -€200,000
Cash 2024 €174,070
Net result for the year +€191,690
Depreciation +€5,600
Stocks and contracts -€3,133
Receivables within one year -€77,530
Deferred charges and accrued income +€650
Trade debts +€18,290
Tax, wage and social debts +€6,697
Other debts -€11,725
Investment in fixed assets (net) -€3,425
Contributions, distributions and other -€200,000
Cash 2025 €101,184
brings cash intakes cash out
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €557,532 €562,484 +€4,952 +0.9%
Fixed assets 21/28 €9,554 €7,378 -€2,175 -22.8%
Tangible fixed assets 22/27 €9,554 €7,378 -€2,175 -22.8%
Plant, machinery and equipment 23 €5,636 €4,794 -€842 -14.9%
Furniture and vehicles 24 €296 - -€296
Other tangible fixed assets 26 €3,622 €2,584 -€1,037 -28.6%
Current assets 29/58 €547,978 €555,105 +€7,127 +1.3%
Stocks and contracts in progress 3 €237,417 €240,551 +€3,133 +1.3%
Stocks 30/36 €237,417 €240,551 +€3,133 +1.3%
Amounts receivable within one year 40/41 €130,724 €208,254 +€77,530 +59.3%
Trade receivables 40 €129,141 €139,364 +€10,222 +7.9%
Other amounts receivable 41 €1,583 €68,891 +€67,308 +4,252%
Cash at bank and in hand 54/58 €174,070 €101,184 -€72,886 -41.9%
Deferred charges and accrued income 490/1 €5,767 €5,116 -€650 -11.3%
Total equity and liabilities 10/49 €557,532 €562,484 +€4,952 +0.9%
Equity 10/15 €247,236 €238,926 -€8,310 -3.4%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €185,236 €176,926 -€8,310 -4.5%
Non-distributable reserves 130/1 €6,200 €6,200 = 0.0%
Legal reserve 130 €6,200 €6,200 = 0.0%
Distributable reserves 133 €179,036 €170,726 -€8,310 -4.6%
Amounts payable 17/49 €310,296 €323,558 +€13,262 +4.3%
Amounts payable within one year 42/48 €310,296 €323,558 +€13,262 +4.3%
Trade debts 44 €74,848 €93,139 +€18,290 +24.4%
Suppliers 440/4 €74,848 €93,139 +€18,290 +24.4%
Taxes, remuneration and social security 45 €22,987 €29,684 +€6,697 +29.1%
Taxes 450/3 €669 €6,122 +€5,453 +816%
Remuneration and social security 454/9 €22,319 €23,563 +€1,244 +5.6%
Other amounts payable 47/48 €212,460 €200,735 -€11,725 -5.5%
Remuneration, social security and pensions 62 €171,348 €186,811 +€15,463 +9.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €7,071 €5,600 -€1,471 -20.8%
Other operating charges 640/8 €1,745 €2,224 +€479 +27.4%
Gross operating margin 9900 €414,589 €451,196 +€36,607 +8.8%
Operating profit (loss) 9901 €234,425 €256,561 +€22,137 +9.4%
Financial income 75/76B €2,414 €1,523 -€891 -36.9%
Recurring financial income 75 €2,414 €1,523 -€891 -36.9%
Financial charges 65/66B €106 €207 +€101 +94.8%
Recurring financial charges 65 €106 €207 +€101 +94.8%
Profit (loss) for the period before taxes 9903 €236,733 €257,878 +€21,145 +8.9%
Income taxes 67/77 €60,743 €66,188 +€5,445 +9.0%
Profit (loss) for the period 9904 €175,990 €191,690 +€15,700 +8.9%
Profit (loss) for the period to be appropriated 9905 €175,990 €191,690 +€15,700 +8.9%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 22 October 2026 via checked.be.